APO Research
Talk to an analyst

APO RESEARCH · REPORT

Skin Active Delivery System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Skin Active Delivery System Market Outlook and Growth Opportunities 2026

5 March 2026201 pages

Choose your research edition.

Industry ResearchSkin Active Delivery System Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Skin Active Delivery System Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Skin Active Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Skin Active Delivery System Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Skin Active Delivery System Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Skin Active Delivery System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Skin Active Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Skin Active Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Skin Active Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Skin Active Delivery System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Skin Active Delivery System market include KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Corium, Nitto, Valeritas, Nanopass Technologies, TheraJect, Inc and Vaxxas, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Skin Active Delivery System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Skin Active Delivery System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Skin Active Delivery System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Skin Active Delivery System market.

Skin Active Delivery System Segment by Company

KINDEVA

Zosano Pharma

Becton-Dickinson(BD)Technologies

Corium

Nitto

Valeritas

Nanopass Technologies

TheraJect, Inc

Vaxxas

Microdermics

Lohmann Therapie-Systeme AG

BASF

3M

Evonik Personal Care

Vantage Personal Care

Minerals Technologies

Bicosome

Skin Active Delivery System Segment by Type

Microcapsules

Base Oil

Microneedle Technology

Skin Active Delivery System Segment by Application

Drug

Cosmetic

Skin Active Delivery System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Skin Active Delivery System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Skin Active Delivery System key companies, revenue, market share, and recent developments.

3. To split the Skin Active Delivery System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Skin Active Delivery System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Skin Active Delivery System significant trends, drivers, influence factors in global and regions.

6. To analyze Skin Active Delivery System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Active Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Skin Active Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Active Delivery System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Skin Active Delivery System industry.

Chapter 3: Detailed analysis of Skin Active Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Skin Active Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Skin Active Delivery System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Skin Active Delivery System Industry Trends Table 2. Skin Active Delivery System Industry Drivers Table 3. Skin Active Delivery System Industry Opportunities and Challenges Table 4. Skin Active Delivery System Industry Restraints Table 5. Global Skin Active Delivery System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Skin Active Delivery System Revenue Share by Company (2021-2026) Table 7. Global Skin Active Delivery System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Skin Active Delivery System Key Company Manufacturing Base & Headquarters Table 9. Global Skin Active Delivery System Company, Product Type & Application Table 10. Global Skin Active Delivery System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Skin Active Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Microcapsules Table 15. Significant Companies of Base Oil Table 16. Significant Companies of Microneedle Technology Table 17. Global Skin Active Delivery System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Skin Active Delivery System Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Skin Active Delivery System Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Skin Active Delivery System Sales Value Share by Type (2021-2026) Table 21. Global Skin Active Delivery System Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Drug Table 23. Significant Companies of Cosmetic Table 24. Global Skin Active Delivery System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Skin Active Delivery System Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Skin Active Delivery System Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Skin Active Delivery System Sales Value Share by Application (2021-2026) Table 28. Global Skin Active Delivery System Sales Value Share by Application (2027-2032) Table 29. Global Skin Active Delivery System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Skin Active Delivery System Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Skin Active Delivery System Sales Value Share by Region (2021-2026) Table 32. Global Skin Active Delivery System Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Skin Active Delivery System Sales Value Share by Region (2027-2032) Table 34. Global Skin Active Delivery System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Skin Active Delivery System Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Skin Active Delivery System Sales Value Market Share by Country (2021-2026) Table 37. Global Skin Active Delivery System Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Skin Active Delivery System Sales Value Market Share by Country (2027-2032) Table 39. KINDEVA Company Information Table 40. KINDEVA Business Overview Table 41. KINDEVA Skin Active Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. KINDEVA Skin Active Delivery System Product Portfolio Table 43. KINDEVA Recent Development Table 44. Zosano Pharma Company Information Table 45. Zosano Pharma Business Overview Table 46. Zosano Pharma Skin Active Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Zosano Pharma Skin Active Delivery System Product Portfolio Table 48. Zosano Pharma Recent Development Table 49. Becton-Dickinson(BD)Technologies Company Information Table 50. Becton-Dickinson(BD)Technologies Business Overview Table 51. Becton-Dickinson(BD)Technologies Skin Active Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Becton-Dickinson(BD)Technologies Skin Active Delivery System Product Portfolio Table 53. Becton-Dickinson(BD)Technologies Recent Development Table 54. Corium Company Information Table 55. Corium Business Overview Table 56. Corium Skin Active Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Corium Skin Active Delivery System Product Portfolio Table 58. Corium Recent Development Table 59. Nitto Company Information Table 60. Nitto Business Overview Table 61. Nitto Skin Active Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Nitto Skin Active Delivery System Product Portfolio Table 63. Nitto Recent Development Table 64. Valeritas Company Information Table 65. Valeritas Business Overview Table 66. Valeritas Skin Active Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Valeritas Skin Active Delivery System Product Portfolio Table 68. Valeritas Recent Development Table 69. Nanopass Technologies Company Information Table 70. Nanopass Technologies Business Overview Table 71. Nanopass Technologies Skin Active Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Nanopass Technologies Skin Active Delivery System Product Portfolio Table 73. Nanopass Technologies Recent Development Table 74. TheraJect, Inc Company Information Table 75. TheraJect, Inc Business Overview Table 76. TheraJect, Inc Skin Active Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. TheraJect, Inc Skin Active Delivery System Product Portfolio Table 78. TheraJect, Inc Recent Development Table 79. Vaxxas Company Information Table 80. Vaxxas Business Overview Table 81. Vaxxas Skin Active Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Vaxxas Skin Active Delivery System Product Portfolio Table 83. Vaxxas Recent Development Table 84. Microdermics Company Information Table 85. Microdermics Business Overview Table 86. Microdermics Skin Active Delivery System Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Microdermics Skin Active Delivery System Product Portfolio Table 88. Microdermics Recent Development Table 89. Lohmann Therapie-Systeme AG Company Information Table 90. Lohmann Therapie-Systeme AG Business Overview Table 91. Lohmann Therapie-Systeme AG Skin Active Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Lohmann Therapie-Systeme AG Skin Active Delivery System Product Portfolio Table 93. Lohmann Therapie-Systeme AG Recent Development Table 94. BASF Company Information Table 95. BASF Business Overview Table 96. BASF Skin Active Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. BASF Skin Active Delivery System Product Portfolio Table 98. BASF Recent Development Table 99. 3M Company Information Table 100. 3M Business Overview Table 101. 3M Skin Active Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. 3M Skin Active Delivery System Product Portfolio Table 103. 3M Recent Development Table 104. Evonik Personal Care Company Information Table 105. Evonik Personal Care Business Overview Table 106. Evonik Personal Care Skin Active Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Evonik Personal Care Skin Active Delivery System Product Portfolio Table 108. Evonik Personal Care Recent Development Table 109. Vantage Personal Care Company Information Table 110. Vantage Personal Care Business Overview Table 111. Vantage Personal Care Skin Active Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Vantage Personal Care Skin Active Delivery System Product Portfolio Table 113. Vantage Personal Care Recent Development Table 114. Minerals Technologies Company Information Table 115. Minerals Technologies Business Overview Table 116. Minerals Technologies Skin Active Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Minerals Technologies Skin Active Delivery System Product Portfolio Table 118. Minerals Technologies Recent Development Table 119. Bicosome Company Information Table 120. Bicosome Business Overview Table 121. Bicosome Skin Active Delivery System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Bicosome Skin Active Delivery System Product Portfolio Table 123. Bicosome Recent Development Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Skin Active Delivery System Product Image Figure 2. Global Skin Active Delivery System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Skin Active Delivery System Market Size (2021-2032) & (US$ Million) Figure 4. Global Skin Active Delivery System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Microcapsules Image Figure 8. Base Oil Image Figure 9. Microneedle Technology Image Figure 10. Global Skin Active Delivery System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Skin Active Delivery System Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Skin Active Delivery System Sales Value Share by Type (2021-2032) Figure 13. Drug Image Figure 14. Cosmetic Image Figure 15. Global Skin Active Delivery System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Skin Active Delivery System Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Skin Active Delivery System Sales Value Share by Application (2021-2032) Figure 18. Global Skin Active Delivery System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Skin Active Delivery System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Skin Active Delivery System Sales Value (2021-2032) & (US$ Million) Figure 21. North America Skin Active Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Skin Active Delivery System Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Skin Active Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Skin Active Delivery System Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Skin Active Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Skin Active Delivery System Sales Value (2021-2032) & (US$ Million) Figure 27. South America Skin Active Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Skin Active Delivery System Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Skin Active Delivery System Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Skin Active Delivery System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Microcapsules
  • Base Oil
  • Microneedle Technology
Applications
  • Drug
  • Cosmetic
Companies covered
  • KINDEVA
  • Zosano Pharma
  • Becton-Dickinson(BD)Technologies
  • Corium
  • Nitto
  • Valeritas
  • Nanopass Technologies
  • TheraJect, Inc
  • Vaxxas
  • Microdermics
  • Lohmann Therapie-Systeme AG
  • BASF
  • 3M
  • Evonik Personal Care
  • Vantage Personal Care
  • Minerals Technologies
  • Bicosome

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Skin Active Delivery System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Skin Active Delivery System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Skin Active Delivery System Market Dynamics
  1. 2.1 Skin Active Delivery System Industry Trends
  2. 2.2 Skin Active Delivery System Industry Drivers
  3. 2.3 Skin Active Delivery System Industry Opportunities and Challenges
  4. 2.4 Skin Active Delivery System Industry Restraints
3 Skin Active Delivery System Market by Company
  1. 3.1 Global Skin Active Delivery System Company Revenue Ranking in 2025
  2. 3.2 Global Skin Active Delivery System Revenue by Company (2021-2026)
  3. 3.3 Global Skin Active Delivery System Company Ranking (2024-2026)
  4. 3.4 Global Skin Active Delivery System Company Manufacturing Base and Headquarters
  5. 3.5 Global Skin Active Delivery System Company Product Type and Application
  6. 3.6 Global Skin Active Delivery System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Skin Active Delivery System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Skin Active Delivery System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Skin Active Delivery System Market by Type
  1. 4.1 Skin Active Delivery System Type Introduction
  2. 4.1.1 Microcapsules
  3. 4.1.2 Base Oil
  4. 4.1.3 Microneedle Technology
  5. 4.2 Global Skin Active Delivery System Sales Value by Type
  6. 4.2.1 Global Skin Active Delivery System Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Skin Active Delivery System Sales Value by Type (2021-2032)
  8. 4.2.3 Global Skin Active Delivery System Sales Value Share by Type (2021-2032)
5 Skin Active Delivery System Market by Application
  1. 5.1 Skin Active Delivery System Application Introduction
  2. 5.1.1 Drug
  3. 5.1.2 Cosmetic
  4. 5.2 Global Skin Active Delivery System Sales Value by Application
  5. 5.2.1 Global Skin Active Delivery System Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Skin Active Delivery System Sales Value by Application (2021-2032)
  7. 5.2.3 Global Skin Active Delivery System Sales Value Share by Application (2021-2032)
6 Skin Active Delivery System Regional Value Analysis
  1. 6.1 Global Skin Active Delivery System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Skin Active Delivery System Sales Value by Region (2021-2032)
  3. 6.2.1 Global Skin Active Delivery System Sales Value by Region: 2021-2026
  4. 6.2.2 Global Skin Active Delivery System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Skin Active Delivery System Sales Value (2021-2032)
  7. 6.3.2 North America Skin Active Delivery System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Skin Active Delivery System Sales Value (2021-2032)
  10. 6.4.2 Europe Skin Active Delivery System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Skin Active Delivery System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Skin Active Delivery System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Skin Active Delivery System Sales Value (2021-2032)
  16. 6.6.2 South America Skin Active Delivery System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Skin Active Delivery System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Skin Active Delivery System Sales Value Share by Country, 2025 VS 2032
7 Skin Active Delivery System Country-level Value Analysis
  1. 7.1 Global Skin Active Delivery System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Skin Active Delivery System Sales Value by Country (2021-2032)
  3. 7.2.1 Global Skin Active Delivery System Sales Value by Country (2021-2026)
  4. 7.2.2 Global Skin Active Delivery System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Skin Active Delivery System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Skin Active Delivery System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Skin Active Delivery System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 KINDEVA
  2. 8.1.1 KINDEVA Company Information
  3. 8.1.2 KINDEVA Business Overview
  4. 8.1.3 KINDEVA Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 KINDEVA Skin Active Delivery System Product Portfolio
  6. 8.1.5 KINDEVA Recent Developments
  7. 8.2 Zosano Pharma
  8. 8.2.1 Zosano Pharma Company Information
  9. 8.2.2 Zosano Pharma Business Overview
  10. 8.2.3 Zosano Pharma Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zosano Pharma Skin Active Delivery System Product Portfolio
  12. 8.2.5 Zosano Pharma Recent Developments
  13. 8.3 Becton-Dickinson(BD)Technologies
  14. 8.3.1 Becton-Dickinson(BD)Technologies Company Information
  15. 8.3.2 Becton-Dickinson(BD)Technologies Business Overview
  16. 8.3.3 Becton-Dickinson(BD)Technologies Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Becton-Dickinson(BD)Technologies Skin Active Delivery System Product Portfolio
  18. 8.3.5 Becton-Dickinson(BD)Technologies Recent Developments
  19. 8.4 Corium
  20. 8.4.1 Corium Company Information
  21. 8.4.2 Corium Business Overview
  22. 8.4.3 Corium Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Corium Skin Active Delivery System Product Portfolio
  24. 8.4.5 Corium Recent Developments
  25. 8.5 Nitto
  26. 8.5.1 Nitto Company Information
  27. 8.5.2 Nitto Business Overview
  28. 8.5.3 Nitto Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nitto Skin Active Delivery System Product Portfolio
  30. 8.5.5 Nitto Recent Developments
  31. 8.6 Valeritas
  32. 8.6.1 Valeritas Company Information
  33. 8.6.2 Valeritas Business Overview
  34. 8.6.3 Valeritas Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Valeritas Skin Active Delivery System Product Portfolio
  36. 8.6.5 Valeritas Recent Developments
  37. 8.7 Nanopass Technologies
  38. 8.7.1 Nanopass Technologies Company Information
  39. 8.7.2 Nanopass Technologies Business Overview
  40. 8.7.3 Nanopass Technologies Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nanopass Technologies Skin Active Delivery System Product Portfolio
  42. 8.7.5 Nanopass Technologies Recent Developments
  43. 8.8 TheraJect, Inc
  44. 8.8.1 TheraJect, Inc Company Information
  45. 8.8.2 TheraJect, Inc Business Overview
  46. 8.8.3 TheraJect, Inc Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TheraJect, Inc Skin Active Delivery System Product Portfolio
  48. 8.8.5 TheraJect, Inc Recent Developments
  49. 8.9 Vaxxas
  50. 8.9.1 Vaxxas Company Information
  51. 8.9.2 Vaxxas Business Overview
  52. 8.9.3 Vaxxas Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vaxxas Skin Active Delivery System Product Portfolio
  54. 8.9.5 Vaxxas Recent Developments
  55. 8.10 Microdermics
  56. 8.10.1 Microdermics Company Information
  57. 8.10.2 Microdermics Business Overview
  58. 8.10.3 Microdermics Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Microdermics Skin Active Delivery System Product Portfolio
  60. 8.10.5 Microdermics Recent Developments
  61. 8.11 Lohmann Therapie-Systeme AG
  62. 8.11.1 Lohmann Therapie-Systeme AG Company Information
  63. 8.11.2 Lohmann Therapie-Systeme AG Business Overview
  64. 8.11.3 Lohmann Therapie-Systeme AG Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lohmann Therapie-Systeme AG Skin Active Delivery System Product Portfolio
  66. 8.11.5 Lohmann Therapie-Systeme AG Recent Developments
  67. 8.12 BASF
  68. 8.12.1 BASF Company Information
  69. 8.12.2 BASF Business Overview
  70. 8.12.3 BASF Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BASF Skin Active Delivery System Product Portfolio
  72. 8.12.5 BASF Recent Developments
  73. 8.13 3M
  74. 8.13.1 3M Company Information
  75. 8.13.2 3M Business Overview
  76. 8.13.3 3M Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  77. 8.13.4 3M Skin Active Delivery System Product Portfolio
  78. 8.13.5 3M Recent Developments
  79. 8.14 Evonik Personal Care
  80. 8.14.1 Evonik Personal Care Company Information
  81. 8.14.2 Evonik Personal Care Business Overview
  82. 8.14.3 Evonik Personal Care Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Evonik Personal Care Skin Active Delivery System Product Portfolio
  84. 8.14.5 Evonik Personal Care Recent Developments
  85. 8.15 Vantage Personal Care
  86. 8.15.1 Vantage Personal Care Company Information
  87. 8.15.2 Vantage Personal Care Business Overview
  88. 8.15.3 Vantage Personal Care Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Vantage Personal Care Skin Active Delivery System Product Portfolio
  90. 8.15.5 Vantage Personal Care Recent Developments
  91. 8.16 Minerals Technologies
  92. 8.16.1 Minerals Technologies Company Information
  93. 8.16.2 Minerals Technologies Business Overview
  94. 8.16.3 Minerals Technologies Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Minerals Technologies Skin Active Delivery System Product Portfolio
  96. 8.16.5 Minerals Technologies Recent Developments
  97. 8.17 Bicosome
  98. 8.17.1 Bicosome Company Information
  99. 8.17.2 Bicosome Business Overview
  100. 8.17.3 Bicosome Skin Active Delivery System Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bicosome Skin Active Delivery System Product Portfolio
  102. 8.17.5 Bicosome Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst